These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3218185
1. [Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease]. Kuz'ko NV. Vrach Delo; 1988 Oct; (10):16-9. PubMed ID: 3218185 [No Abstract] [Full Text] [Related]
2. [Effect of Sensit on central hemodynamics in patients with ischemic heart disease]. Kliuka GR, Sinitsa KI, Okhon'ko VI, Sinitsa TN, Pilipchuk LR. Vrach Delo; 1987 Nov; (11):19-20. PubMed ID: 3439113 [No Abstract] [Full Text] [Related]
3. [Fendiline brings oxygen to the myocardium]. von Bock und Polach U. Med Klin; 1981 Sep 11; 76(19):541-4. PubMed ID: 7024764 [No Abstract] [Full Text] [Related]
4. Observations made with Sensit in the treatment of angina pectoris patients. Keller L, Landi A. Ther Hung; 1983 Sep 11; 31(4):176-80. PubMed ID: 6400457 [No Abstract] [Full Text] [Related]
5. [Fendiline (Sensit) in the treatment of coronary disease]. Bała T, Gajewska B, Adamska-Dyniewska H. Wiad Lek; 1983 Apr 01; 36(7):525-30. PubMed ID: 6349131 [No Abstract] [Full Text] [Related]
6. [Use of riboxin in treating patients with chronic ischemic heart disease]. Lanovaia NI, Neĭko EM. Vrach Delo; 1986 Aug 01; (8):17-9. PubMed ID: 3776150 [No Abstract] [Full Text] [Related]
7. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)]. Reiterer W. Wien Med Wochenschr; 1980 Dec 15; 130(23):772-7. PubMed ID: 6111161 [Abstract] [Full Text] [Related]
8. [Role of calcium antagonists in therapy of coronary heart disease. Experimental report on the calcium antagonist fendiline, and the beta receptor blockader metoprolol]. Ardjah H. Med Welt; 1980 Sep 12; 31(37):1326-30. PubMed ID: 7432128 [No Abstract] [Full Text] [Related]
9. [Causes and treatment of coronary failure]. Kutscha W. Fortschr Med Suppl; 1986 Sep 12; 3():15-8. PubMed ID: 2870963 [No Abstract] [Full Text] [Related]
13. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease. Winniford MD, Hillis LD. Herz; 1982 Aug 12; 7(4):243-9. PubMed ID: 6127300 [No Abstract] [Full Text] [Related]
14. [Effect of sensit on the course of ischemic heart disease]. Nesvetov VN, Gorshkov VA, Kuliamin VI, Buskin VD. Sov Med; 1988 Aug 12; (3):57-61. PubMed ID: 3413552 [No Abstract] [Full Text] [Related]
15. [Lipid peroxidation as an indicator of the effectiveness of treating patients with chronic ischemic heart disease using a helium-neon laser]. Katel'nitskaia LI, Khodareva NK, Glushko AB. Klin Med (Mosk); 1989 Jul 12; 67(7):37-9. PubMed ID: 2572722 [Abstract] [Full Text] [Related]
16. [Value of the combination of trimetazidine and a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo]. Brochier M, Demange J, Ducloux G, Monpère C, Warin JF. Ann Cardiol Angeiol (Paris); 1986 Jan 12; 35(1):49-56. PubMed ID: 3516053 [No Abstract] [Full Text] [Related]
17. [Mechanism of the anti-anginal action of korinfar]. Sadkovaia RM, Zin'kovskaia TM, Golubev AD. Farmakol Toksikol; 1986 Jan 12; 49(5):90-2. PubMed ID: 3770183 [Abstract] [Full Text] [Related]
18. [Effectiveness of inosine derivatives in patients with ischemic heart disease]. Kuz'ko NV. Vrach Delo; 1977 Aug 12; (8):25-8. PubMed ID: 919441 [No Abstract] [Full Text] [Related]